Related Experiment Video
Updated: Jun 26, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
The United Kingdom Expert Patients Programme: results and implications from a national evaluation
Anne Rogers1, Anne Kennedy, Peter Bower
1National Primary Care Research and Development Centre, University of Manchester, Manchester, UK. anne.rogers@manchester.ac.uk
Abstract:
The Expert Patients Programme (EPP) is a central element of chronic disease management policy in the United Kingdom. It aims to deliver self-care support by developing peoples' self-care skills, confidence and motivation to take more effective control over their long-term conditions. A large, national randomised controlled trial found that the EPP's lay-led skills training was effective in improving self-efficacy and energy levels among patients with long-term conditions, and was likely to be cost-effective. Key questions remain as to whether existing outcome measures capture the core outcomes that are important to patients with long-term conditions. The development and evaluation of self-care support initiatives should take into account the extent to which self-care support initiatives can be integrated into peoples' everyday lives, and the degree of fit with patients' existing adaptations and strategies. Rather than being concentrated on a single course, central resources for self-management support should be directed at a variety of systems and interventions that are able to meet the wide range of needs of patients with chronic conditions.
Related Concept Videos
Nursing Evaluation
Section...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Bioavailability Study Design: Healthy Subjects Versus Patients
Analysis of Population Pharmacokinetic Data